Causin C, Waheed A, Braulke T, Junghans U, Maly P, Humbel R E, von Figura K
Biochemie II, Georg-August-Universität Göttingen, Federal Republic of Germany.
Biochem J. 1988 Jun 15;252(3):795-9. doi: 10.1042/bj2520795.
Human serum and urine contain polypeptides which bind mannose 6-phosphate (M6P) and insulin-like growth factor II (IGF II) and crossreact with antibodies against the M6P/IGF II receptor. These polypeptides are considered to be fragments of the M6P/IGF II receptor. The major Mr approx. 205,000 fragment in serum and urine is about 10 kDa smaller in size than the membrane-associated receptor and is accompanied by minor forms with Mr values ranging from 104,000 to 180,000. The presence of receptor fragments in biological fluids indicates that shedding is one of the mechanisms contributing to the turnover of the M6P/IGF II receptor and that receptor fragments are part of the heterogenous group of serum proteins whic bind IGF II.
人血清和尿液中含有能结合甘露糖6-磷酸(M6P)和胰岛素样生长因子II(IGF II)并与抗M6P/IGF II受体抗体发生交叉反应的多肽。这些多肽被认为是M6P/IGF II受体的片段。血清和尿液中主要的Mr约为205,000的片段比膜相关受体小约10 kDa,并伴有Mr值在104,000至180,000之间的次要形式。生物体液中存在受体片段表明,脱落是导致M6P/IGF II受体更新的机制之一,并且受体片段是结合IGF II的异质性血清蛋白组的一部分。